Alto Ingredients (ALTO) Cash & Equivalents (2010 - 2026)

Alto Ingredients has reported Cash & Equivalents for 17 years, with the latest figure at $20.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 24.16% year-over-year to $20.3 million; the trailing twelve-month figure through Mar 2026 stood at $20.3 million (down 24.16% YoY), and the FY2025 full-year result was $23.4 million, down 33.98% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $20.3 million, down from $23.4 million in the prior quarter.
• The five-year high for Cash & Equivalents was $57.4 million in Q2 2022, with the low at $20.3 million in Q1 2026.
• Historically, Cash & Equivalents has averaged $30.4 million across 5 years, with a median of $29.3 million in 2024.
• Annual changes were most pronounced in 2023 — Cash & Equivalents sank 60.37% — and 2024, when it surged 38.43%.
• Alto Ingredients' Cash & Equivalents stood at $36.5 million in 2022, then declined by 17.67% to $30.0 million in 2023, then increased by 18.17% to $35.5 million in 2024, then slumped by 33.98% to $23.4 million in 2025, then fell by 13.27% to $20.3 million in 2026.
• The last three Cash & Equivalents figures came in at $20.3 million (Q1 2026), $23.4 million (Q4 2025), and $32.5 million (Q3 2025), per Business Quant data.